These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Behavioral effects of the novel cannabinoid full agonist AM 411. McLaughlin PJ; Lu D; Winston KM; Thakur G; Swezey LA; Makriyannis A; Salamone JD Pharmacol Biochem Behav; 2005 May; 81(1):78-88. PubMed ID: 15894067 [TBL] [Abstract][Full Text] [Related]
3. Effects of AM1346, a high-affinity CB1 receptor selective anandamide analog, on open-field behavior in rats. Järbe TU; DiPatrizio NV; Li C; Makriyannis A Behav Pharmacol; 2007 Nov; 18(7):673-80. PubMed ID: 17912052 [TBL] [Abstract][Full Text] [Related]
4. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study. Oviedo A; Glowa J; Herkenham M Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305 [TBL] [Abstract][Full Text] [Related]
5. Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice. Vigolo A; Ossato A; Trapella C; Vincenzi F; Rimondo C; Seri C; Varani K; Serpelloni G; Marti M Neuropharmacology; 2015 Aug; 95():68-82. PubMed ID: 25769232 [TBL] [Abstract][Full Text] [Related]
6. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity. Katsidoni V; Kastellakis A; Panagis G Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148 [TBL] [Abstract][Full Text] [Related]
7. Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies. Canazza I; Ossato A; Trapella C; Fantinati A; De Luca MA; Margiani G; Vincenzi F; Rimondo C; Di Rosa F; Gregori A; Varani K; Borea PA; Serpelloni G; Marti M Psychopharmacology (Berl); 2016 Oct; 233(21-22):3685-3709. PubMed ID: 27527584 [TBL] [Abstract][Full Text] [Related]
8. PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats. Horswill JG; Bali U; Shaaban S; Keily JF; Jeevaratnam P; Babbs AJ; Reynet C; Wong Kai In P Br J Pharmacol; 2007 Nov; 152(5):805-14. PubMed ID: 17592509 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats. Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490 [TBL] [Abstract][Full Text] [Related]
10. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM; Wakley AA; Tsutsui KT; Laggart JD J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934 [TBL] [Abstract][Full Text] [Related]
11. Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus. Grzeda E; Schlicker E; Luczaj W; Harasim E; Baranowska-Kuczko M; Malinowska B J Physiol Pharmacol; 2015 Jun; 66(3):343-53. PubMed ID: 26084216 [TBL] [Abstract][Full Text] [Related]
12. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. Welch SP; Huffman JW; Lowe J J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392 [TBL] [Abstract][Full Text] [Related]
13. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats. Järbe TU; Liu Q; Makriyannis A Psychopharmacology (Berl); 2006 Jan; 184(1):36-45. PubMed ID: 16307294 [TBL] [Abstract][Full Text] [Related]
14. (-)-Adamantyl-delta8-tetrahydrocannabinol (AM-411), a selective cannabinoid CB1 receptor agonist: effects on open-field behaviors and antagonism by SR-141716 in rats. Järbe TU; DiPatrizio NV; Lu D; Makriyannis A Behav Pharmacol; 2004 Nov; 15(7):517-21. PubMed ID: 15472574 [TBL] [Abstract][Full Text] [Related]
15. The selective cannabinoid antagonist SR 141716A blocks cannabinoid-induced antinociception in rats. Lichtman AH; Martin BR Pharmacol Biochem Behav; 1997; 57(1-2):7-12. PubMed ID: 9164547 [TBL] [Abstract][Full Text] [Related]
16. CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour. Rubino T; Guidali C; Vigano D; Realini N; Valenti M; Massi P; Parolaro D Neuropharmacology; 2008 Jan; 54(1):151-60. PubMed ID: 17692344 [TBL] [Abstract][Full Text] [Related]
17. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Wiley JL; Barrett RL; Lowe J; Balster RL; Martin BR Neuropharmacology; 1995 Jun; 34(6):669-76. PubMed ID: 7566504 [TBL] [Abstract][Full Text] [Related]
18. Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats. Xi ZX; Spiller K; Pak AC; Gilbert J; Dillon C; Li X; Peng XQ; Gardner EL Neuropsychopharmacology; 2008 Jun; 33(7):1735-45. PubMed ID: 17728698 [TBL] [Abstract][Full Text] [Related]
20. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids. Janoyan JJ; Crim JL; Darmani NA Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]